GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (NEOE:CBST) » Definitions » EBITDA Margin %

Cannabist Company Holdings (NEOE:CBST) EBITDA Margin % : -1.85% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Cannabist Company Holdings's EBITDA for the three months ended in Mar. 2024 was C$-3.1 Mil. Cannabist Company Holdings's Revenue for the three months ended in Mar. 2024 was C$166.0 Mil. Therefore, Cannabist Company Holdings's EBITDA margin for the quarter that ended in Mar. 2024 was -1.85%.


Cannabist Company Holdings EBITDA Margin % Historical Data

The historical data trend for Cannabist Company Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabist Company Holdings EBITDA Margin % Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial -122.92 -61.20 -13.84 -57.47 -10.03

Cannabist Company Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.65 3.78 -1.71 -43.62 -1.85

Competitive Comparison of Cannabist Company Holdings's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabist Company Holdings's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Cannabist Company Holdings's EBITDA Margin % falls into.



Cannabist Company Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Cannabist Company Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-68.829/685.996
=-10.03 %

Cannabist Company Holdings's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-3.069/165.966
=-1.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabist Company Holdings  (NEOE:CBST) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Cannabist Company Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabist Company Holdings (NEOE:CBST) Business Description

Traded in Other Exchanges
Address
680 Fifth Avenue, 24th Floor, New York, NY, USA, 10019
Cannabist Company Holdings Inc Formerly Columbia Care Inc is a cultivator, manufacturer, and provider of medical cannabis products and services. Some of its products are Vaporization Oil, Sublingual Tinctures, Lotions, Hard Pressed Tablets, and Suppositories, among others. The company markets its products under Amber, ClaraCeed, Press, Platinum label, Platinum Partners, Seed & Starin, and Triple 777 brands.
Executives
Alison Worthington Director

Cannabist Company Holdings (NEOE:CBST) Headlines

No Headlines